Dalton Pharma Services Licenses Thermo Fisher Scientific Enter Drug Development Agreement

News   May 07, 2008

 
Dalton Pharma Services Licenses Thermo Fisher Scientific Enter Drug Development Agreement
 
 
 

RELATED ARTICLES

Chemists Design More Efficient Microreactor Using 3D Printing

News

Researchers developed an electrochemical microreactor using additive manufacturing technology (commonly known as 3D printing). The newly developed microreactor was tested on synthesis of isoindolinones, which are found in many natural products, pharmaceuticals, and biologically active molecules.

READ MORE

Novel Chemistry Technique Simplifies Late-Stage Modification of Drug Compounds

News

Chemists at The Scripps Research Institute (TSRI) have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.

READ MORE

Revolutionary Imaging Technique Uses CRISPR to Map DNA Mutations

News

The new high-speed AFM method can map DNA to a resolution of tens of base pairs while creating images up to a million base pairs in size. And it does it using a fraction of the amount of specimen required for DNA sequencing.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE